Cancer Cure?

ROME, JAN. 22, 2009 (Zenit.org).- Imagine a medicine that has a staggering 75% success rate in treating cancer, and yet is a natural and ethical product, owned by a nonprofit company headed by devout Catholics.

Too good to be true? That's what I thought. The medical world is not short of bogus cancer "cures." Treatment for the disease is a multi-billion dollar industry that has led to questionable or unproven methods springing up throughout the world.

Yet this little-known product, which works by rebuilding the body's own adult stem cells and destroying tumour cells, already has a 25-year track record as a highly effective cancer treatment. Called CellAdam, it is most effective in preventing the early stages of cancer. But it also impedes the malignant process, and has an analgesic effect in the hopeless stage of an advanced tumour. Because of its natural composition, it has none of the hallucinogenic effects you get with morphine. The ingredients simply include a fatty acid complex extracted from soy and sunflower.

Let's get this out there!

No Breast Cancer For This Baby

The first baby in the UK tested before conception for a genetic form of breast cancer has been born.

Doctors at University College London said the girl and her mother were doing well following the birth this week.

The embryo was screened for the altered BRCA1 gene, which would have meant the girl had a 80% chance of developing breast cancer.

Women in three generations of her husband's family have been diagnosed with the disease in their 20s. - BBC News

We probably wouldn't have heard about this if the baby did have the gene. That'd be eugenics. And wrong.

Breast Cancer Inversely Proportionate To...

(AP) -- Women who perform the act of fellatio and swallow semen on a regular basis, one to two times a week, may reduce their risk of breast cancer by up to 40 percent, a North Carolina State University study found.

Doctors had never suspected a link between the act of fellatio and breast cancer, but new research being performed at North Carolina State University is starting to suggest that there could be an important link between the two.

The most awkward Étudiant post in quite a while.

Biotech lobbies Congress

Geoffrey Allan has been giving Congress a lesson in biotechnology.

He's explained protein structures and how they work. He's reviewed how drugs are absorbed into the body.

If lawmakers understand the difference between chemical and biologic drugs, Allan reasons, they'll be more invested in his cause: getting quick approval for generic biotech drugs.

Let's hope Congress approves Allan's idea, because these drugs could help cancer patients.

Today the generics market for chemical drugs like aspirin is booming, but there is no way to get cheaper copies of pricey biologics, for complex life-threatening diseases like cancer, into patients' hands.

Virtually Killing Cancer Boosts Morale

When 12-year-old Taylor Carol contracted a rare, virulent form of leukemia, it took aggressive medical treatment to save his life. That and a video game.

Taylor gives part of the credit for his recovery to the hours he spent playing Re-Mission, a computer game that lets children with cancer fight back by zapping simulated cancer cells.

"It's just such a morale boost, being able to kill what's been keeping you in the hospital bed and away from your friends," Taylor said.

His father, Jim Taylor, a technology entrepreneur and philanthropist in Dana Point, Calif., said the game helped his son endure a painful bone marrow transplant and months of chemotherapy.

"When a kid has cancer, everything's being done to them," he said. "The game gave the kid a chance to feel like he was in charge." - The Boston Globe

"Video games harm children." Yeah right.

Cancer Detection Chip

A silicon chip the size of a business card could soon speed cancer diagnoses, track treatment more closely, and discover earlier signs of recurrences.

Researchers from Massachusetts General Hospital have developed a better technique for collecting and measuring the cells that escape from tumors and travel through the bloodstream, spreading cancer from one part of the body to another.

These so-called circulating tumor cells have been difficult to study, and little is known about them - but tracking them down has been a major goal of scientific research for decades.

Technology these days!